Oncology Review Symposium
Presented by Vanderbilt School of Medicine and Vanderbilt-Ingram Cancer Center
Saturday, June 21, 2008
Loews Vanderbilt Hotel
Nashville, Tennessee
The Vanderbilt-Ingram Cancer Center Oncology Review Symposium is designed for health care professionals who are unable to attend the American Society of Clinical Oncology (ASCO) annual meeting in June, as well as for those who want more in-depth unbiased information on the latest scientific and clinical findings in cancer care.
Directed by Drs. Bruce Roth and Alan Sandler of Vanderbilt-Ingram Cancer Center, this CME conference touts a distinguished faculty from Vanderbilt-Ingram Cancer Center. Topics include all solid tumor types and lymphoma.
Symposium participants will receive a comprehensive review of the major highlights of the 2008 ASCO meeting, a discussion of the practice-changing implications and a new perspective on cancer research with relevance for the practicing clinician.
Target Audience
This activity is designed for medical, surgical and radiation oncologists, oncology nurses, research nurses/coordinators, pharmacists, administrators, data managers and regulatory specialists who are unable to attend the 2008 ASCO meeting; and for those who seek a more in-depth knowledge of the latest scientific and clinical findings in oncology care.
Learning Objectives
At the conclusion of this activity, participants should be able to discuss and describe:
- How the advances in cancer prevention, screening and diagnosis may decrease morbidity and mortality in patients
- Screening and detection of potential prognostic and predictive markers, and evaluation of their possible use towards improved treatment courses
- The evaluation of the latest potential therapies and how to weigh them against current standard of care treatments to apply the most optimal strategies to affect anticipated long-term patient outcomes
- The evaluation of the safety and efficacy of combinations of targeted agents in the treatment of cancer based on recent clinical studies
- The results of recent research efforts, the design and rationale of ongoing studies and the optimization of these techniques for application and follow up in today’s clinical practices to determine the efficacy of these treatments for continued optimal patient care
- The comparison and contrast of outcomes for currently used treatments and apply this knowledge for effective management of pharmacological, radiological and surgical treatment strategies based on individual patient need
Accreditation
Vanderbilt University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Designation of Credit
Vanderbilt University School of Medicine designates this educational activity for a maximum of 7.5 AMA PRA Category 1 Credits(s)TM Physician’s should claim credit commensurate with the extent of their participation in the activity.
Disclosure Statement
It is the policy of Vanderbilt University School of Medicine that participants in CME activities, be made aware of any affiliation or financial interest that may affect the speaker’s presentation(s). Each speaker has completed and signed a conflict of interest statement. The faculty members’ relationships will be disclosed to the audience.
Acknowledgments
Vanderbilt School of Medicine and Vanderbilt-Ingram Cancer Center expresses great appreciation to the following companies for their support of this educational activity by providing an unrestricted educational grant.
- Genentech, Inc.
- Bristol-Meyers Squibb Company
- Eli Lilly
- Novartis
- Abraxis And Astra Zeneca
- Biogen Idec
- Merck
- Celgene
- Osi
- Wyeth
Faculty
- Symposium Chair
Bruce Roth, MD
Professor of Medicine and Urologic Surgery
The Paul V. Hamilton, M.D., and Virginia E. Howd Professor of Urologic Oncology
Section Chief, Solid Tumor Oncology
Co-Director, Genitourinary Oncology Program, Division Of Hematology/Oncology
Medical Oncologist
Vanderbilt-Ingram Cancer Center - Symposium Director
Alan Sandler, MD
Associate Professor of Medicine, Hematology/Oncology Division
Medical Director, Thoracic Oncology
Director, Vanderbilt-Ingram Cancer Center Affiliate Network Program
Medical Oncologist
Vanderbilt-Ingram Cancer Center
Presenting Faculty
- Igor Puzanov, MD
Vanderbilt-Ingram Cancer Center - Jeff Sosman, MD
Vanderbilt-Ingram Cancer Center - Madan Jagasia, MD
Vanderbilt-Ingram Cancer Center - Ingrid Mayer, MD
Vanderbilt-Ingram Cancer Center - Barbara Murphy, MD
Vanderbilt-Ingram Cancer Center - Emily Chan, MD
Vanderbilt-Ingram Cancer Center - Laura Williams Goff, MD
Vanderbilt-Ingram Cancer Center - Alan Sandler, MD
Vanderbilt-Ingram Cancer Center - David Morgan, MD
Vanderbilt-Ingram Cancer Center - Bruce Roth, MD
Vanderbilt-Ingram Cancer Center
